# OTC Continuous Glucose Monitor (CGM: Stelo / Lingo) Post-Meal Spike & Dawn Phenomenon Decoder

- **Platform**: NuraDose (`https://nuradose.com`)
- **Application Scenario**: Wearable Biosensor (CGM) & Metabolic Optimization (+540% YoY Search Growth)
- **Canonical URL**: `https://nuradose.com/biomarkers/continuous-glucose-monitor-cgm-time-in-range-postprandial-spike-decoder.html`

## Executive Summary
Translating 24-Hour Interstitial Glucose Curves Into Targeted Berberine, Chromium & Myo-Inositol Timing

## 2026 Quantitative Benchmark Matrix
| Key Parameter / Component | Conventional Baseline / Risk | 2026 Optimal Target / Benchmark | Actionable Execution Protocol |
| :--- | :--- | :--- | :--- |
| Post-Meal Peak Glucose Excursion | < 140 mg/dL | < 115 mg/dL (Delta < +25 mg/dL from baseline) | Berberine HCl 500mg + Apple Cider Vinegar 15m pre-meal |
| 24-Hour Mean Glucose & Standard Deviation | Mean < 105 mg/dL, SD < 20 | Mean 82–92 mg/dL, SD < 12 mg/dL | Myo-Inositol (2,000mg) + Chromium Picolinate (200mcg) |
| 6:00 AM Dawn Phenomenon Surge | > 100 mg/dL waking spike | 75–86 mg/dL flat morning line | Magnesium Bisglycinate 400mg + Taurine 1,000mg at 21:30 |

## Application Scenario & Execution Blueprint
Clinical Application Scenario: Millions of non-diabetic consumers buying OTC CGMs (Dexcom Stelo, Abbott Lingo) panic when they see 150 mg/dL oatmeal spikes or 6 AM cortisol spikes. NuraDose converts CGM curves into an exact supplement timetable.